|
|
| ID11904 / Ildong (0 Trials) |
|
| ID119160021 / Ildong (0 Trials) |
|
| ID120040002 / Ildong (0 Trials) |
|
| ID1201 / Ildong (0 Trials) |
|
| Idacio (adalimumab-aacf) / Fresenius Kabi (0 Trials) |
|
| idalopirdine (Lu AE58054) / Otsuka, Eli Lilly, Denovo (0 Trials) |
|
| idarubicin hydrochloride / Generic mfg. (114 Trials) |
|
| idasanutlin (RG7388) / Roche (4 Trials) |
|
| idazoxan (RX 781094) / Houston Pharma (1 Trials) |
|
| idazoxan extended release (TR-01) / Terran Biosci (0 Trials) |
|
| IDB003 / Vanderbilt University, IDBiologics, Twist Biosci (0 Trials) |
|
| IDB361 / Ideaya Biosci (0 Trials) |
|
| IDC-G305 / Merck (MSD) (0 Trials) |
|
| IDC001 / Prestige BioPharma (0 Trials) |
|
| IDC002 / Prestige BioPharma (0 Trials) |
|
| IDC004 / Prestige BioPharma (0 Trials) |
|
| IDC007 / Prestige BioPharma (0 Trials) |
|
| IDC008 / Prestige BioPharma (0 Trials) |
|
| IDC009 / Prestige BioPharma (0 Trials) |
|
| IDE161 / Ideaya Biosci (0 Trials) |
|
| IDE397 / Ideaya Biosci (0 Trials) |
|
| IDE697 / Ideaya Biosci (0 Trials) |
|
| idebenone / Generic mfg. (18 Trials) |
|
| Idefirix (imlifidase) / Hansa Biopharma, Sarepta Therap (8 Trials) |
|
| IDegLira (insulin degludec/liraglutide) / Novo Nordisk (5 Trials) |
|
| Idelvion (albutrepenonacog alfa) / CSL Behring (2 Trials) |
|
| idetrexed (CT900) / Algok Bio (0 Trials) |
|
| IDG16177 / Evotec, Ildong (0 Trials) |
|
| IDH1 inhibitor / SignalRx (0 Trials) |
|
| IDH1R132H peptide vaccine / German Cancer Research Center (0 Trials) |
|
| IDH305 / Novartis (1 Trials) |
|
| Idhifa (enasidenib) / BMS, Servier (26 Trials) |
|
| idiopathic inflammatory myopathy therapeutic / Marathon (0 Trials) |
|
| Idiopathic Pulmonary Fibrosis therapeutic / AstraZeneca, Ethris (0 Trials) |
|
| Idiopathic Pulmonary Fibrosis therapeutic / Sanofi (0 Trials) |
|
| Idiopathic Pulmonary Fibrosis therapeutic / Unity Biotech (0 Trials) |
|
| Idiopathic pulmonary fibrosis therapeutic / AbCellera (0 Trials) |
|
| IdioVax (NHL vaccine) / CellGenix (0 Trials) |
|
| IDL-2965 / Indalo Therap (0 Trials) |
|
| IDN 5243 / Indena (0 Trials) |
|
| IDO 8 / Idogen (0 Trials) |
|
| IDO inhibitor / Redx (0 Trials) |
|
| IDO inhibitor / Ensemble Therap (0 Trials) |
|
| IDO inhibitor / HUYA Bioscience (0 Trials) |
|
| IDO inhibitor / Roche, Curadev (0 Trials) |
|
| IDO/TDO dual inhibitor / Lumos Pharma (0 Trials) |
|
| IDO/TDO dual inhibitor / Shizuoka Prefectural University, CanBas (0 Trials) |
|
| IDO1 Inhibitor / Merck (MSD) (0 Trials) |
|
| IDO1 inhibitor / Netherlands Translational Research Center (0 Trials) |
|
| IDP-023 / Indapta Therap (0 Trials) |
|
| IDP-121 / IDP Discovery Pharma (0 Trials) |
|
| IDP-233 / IDP Discovery Pharma (0 Trials) |
|
| IDP-312 / IDP Discovery Pharma (0 Trials) |
|
| IDP-601 / IDP Discovery Pharma (0 Trials) |
|
| idraparinux sodium (SANORG 34006) / Sanofi (0 Trials) |
|
| idrevloride (P-1037) / Parion Sciences (0 Trials) |
|
| Idrofos (ibandronic acid) / Sun Pharma (0 Trials) |
|
| IDRX-42 / IDRx (0 Trials) |
|
| IDRX-73 / IDRx (0 Trials) |
|
| iduronate 2-sulfatase (DNL310) / Denali Therap (0 Trials) |
|
| iduronicrin genleukocel-T (ISP-001) / Immusoft (0 Trials) |
|
| idursulfase-IT (TAK-609) / Takeda (0 Trials) |
|
| IDX 184 / Merck (MSD) (0 Trials) |
|
| IDX 375 / Novartis, Merck (MSD) (0 Trials) |
|
| IDX-320 / Merck (MSD) (0 Trials) |
|
| IDX21459 / Merck (MSD) (0 Trials) |
|
| IEC-001 / Imvax (0 Trials) |
|
| ieramilimab (LAG525) / Novartis (3 Trials) |
|
| ifabotuzumab (KB004) / Humanigen (0 Trials) |
|
| ifabotuzumab ADC / Humanigen (0 Trials) |
|
| ifebemtinib (IN10018) / InxMed (10 Trials) |
|
| ifenprodil (NP-120) / Seyltx (0 Trials) |
|
| ifenprodil intravenous (NP-120 intravenous) / Algernon Pharma (0 Trials) |
|
| ifenprodil tartrate / Chiba University Hospital (0 Trials) |
|
| ifidancitinib (ATI-502) / Aclaris, Rigel (0 Trials) |
|
| ifinatamab deruxtecan (DS-7300) / Daiichi Sankyo, Merck (MSD) (0 Trials) |
|
| IFN-a 2b / Zydus Lifesci (0 Trials) |
|
| IFN-α / Theraclone Sciences (0 Trials) |
|
| IFN-β-1a biosimilar / Harvest Moon (0 Trials) |
|
| ifosfamide / Generic mfg. (133 Trials) |
|
| ifosfamide analog (10118) / Atlanthera (0 Trials) |
|
| IFx-2.0 / TuHURA Bio (0 Trials) |
|
| IG AI 025 / Indigene Pharma (0 Trials) |
|
| IG MD 011 / Indigene Pharma (0 Trials) |
|
| IG MD 020 / Indigene Pharma (0 Trials) |
|
| IgA antibody / BeiGene, Atreca, IGM Biosciences (0 Trials) |
|
| IgA protease / IGAN BioSci, Cartesian Therap (0 Trials) |
|
| IgA proteases / IGAN BioSci (0 Trials) |
|
| Igalmi (dexmedetomedine sublingual) / BioXcel (0 Trials) |
|
| IGC-501 / IGC Pharma (0 Trials) |
|
| IgE Inhibitor / Interprotein Corp (0 Trials) |
|
| IgG-RFB4-SMPT-dgA / National Cancer Institute (0 Trials) |
|
| IGM-2537 / IGM Biosciences (0 Trials) |
|
| IGM-2644 / IGM Biosciences (0 Trials) |
|
| IGM-6268 / Atreca, BeiGene, IGM Biosciences (0 Trials) |
|
| IGM-7354 / IGM Biosciences (0 Trials) |
|
| IgM anti-GITR antibody / IGM Biosciences (0 Trials) |
|
| IGN381 / Igenica Biotherapeutics (0 Trials) |
|
| IGN523 / Igenica Biotherapeutics (0 Trials) |
|
| IGN786 / Pierre Fabre (0 Trials) |
|
| IGP002 / Imago Pharma (0 Trials) |
|
| igrelimogene litadenorepvec (TILT-123) / Tilt Biotherap (0 Trials) |
|
| IGV-001 / Imvax (0 Trials) |
|
| IHV-001 / Imvax (0 Trials) |
|
| Ii-Key Peptide-based Covid-19 vaccine / Shandong Academy of Sciences, Generex (0 Trials) |
|
| Ii-Key-nCOV peptide vaccine / Generex, EpiVax (0 Trials) |
|
| IK-175 / Ikena Oncology (0 Trials) |
|
| IK-412 / Ikena Oncology (0 Trials) |
|
| IK-595 / Ikena Oncology (0 Trials) |
|
| IK-7002 / Mallinckrodt (0 Trials) |
|
| IK-930 / Ikena Oncology (0 Trials) |
|
| IKS01 / Iksuda Therap (0 Trials) |
|
| IKS012 / Iksuda Therap (0 Trials) |
|
| IKS02 / Iksuda Therap (0 Trials) |
|
| IKS03 / Iksuda Therap (0 Trials) |
|
| IKS04 / Iksuda Therap (0 Trials) |
|
| IkT-1427 / Inhibikase (0 Trials) |
|
| IkT-148x / Inhibikase (0 Trials) |
|
| IKT-201 / Ansun Biopharma (0 Trials) |
|
| IKT-202 / Ansun Biopharma (0 Trials) |
|
| IKT-203 / Ansun Biopharma (0 Trials) |
|
| IKT-701 / Ansun Biopharma (0 Trials) |
|
| IKT-702 / Ansun Biopharma (0 Trials) |
|
| IKT-703 / Ansun Biopharma (0 Trials) |
|
| IKT-901 / Ansun Biopharma (0 Trials) |
|
| IKT-902 / Ansun Biopharma (0 Trials) |
|
| IKT-903 / Ansun Biopharma (0 Trials) |
|
| IKT-904 / Ansun Biopharma (0 Trials) |
|
| IKT-905 / Ansun Biopharma (0 Trials) |
|
| IKT-906 / Ansun Biopharma (0 Trials) |
|
| IKT-907 / Ansun Biopharma (0 Trials) |
|
| IL-12 based therapeutic / Mural Oncology (0 Trials) |
|
| IL-12 engineered TIL / National Cancer Institute (0 Trials) |
|
| IL-13Rα2 UCAR-T cell therapy / Suzhou Maximum Bio-tech (0 Trials) |
|
| IL-15 DC / Baylor University (0 Trials) |
|
| IL-15 MAGE A4 autologous SPEAR T cells / Adaptimmune (0 Trials) |
|
| IL-17/IL-23 biAb / BMS (0 Trials) |
|
| IL-17E / Aptose Biosci (0 Trials) |
|
| IL-17RC / BMS, EMD Serono (0 Trials) |
|
| IL-18 based therapeutic / Mural Oncology (0 Trials) |
|
| IL-2 ActoBiotic / Alaunos Therap, Precigen (0 Trials) |
|
| IL-2 XL / Avadel (0 Trials) |
|
| IL-22 partial agonist program / Synthekine (0 Trials) |
|
| IL-23/CGRP Bispecific Antibody / Eli Lilly (0 Trials) |
|
| IL-24-CTV / InterLeukin Combinatorial Therapies (0 Trials) |
|
| IL-35 agonist / Tizona Therap (0 Trials) |
|
| IL-35 antagonist / Tizona Therap (0 Trials) |
|
| IL-4/13 inhibitor / Synairgen (0 Trials) |
|
| IL-5 inhibitor / ENovate Biolife (0 Trials) |
|
| IL-7 MAGE A4 autologous SPEAR T cells / Adaptimmune (0 Trials) |
|
| IL-KTM (anakinra biosimilar) / Paras Biopharma (0 Trials) |
|
| IL-YANG FLU Vaccine Prefilled Syringe INJ (influenza virus vaccine quadrivalent) / IL-Yang Pharm (0 Trials) |
|
| IL13Rα2xCD3 bispecific DART / MacroGenics (0 Trials) |
|
| IL15-NK cells / Chongqing Sidemu Biotechnology Technology (0 Trials) |
|
| IL23R-CAR-Treg / Sangamo Therap (0 Trials) |
|
| IL3 CAR-T cell therapy / Shanghai Yake Biotech (0 Trials) |
|
| IL3 zetakine expressing CD123 CAR-T / Vor Biopharma (0 Trials) |
|
| IL3R CAR-T / Sorrento (0 Trials) |
|
| iladatuzumab vedotin (DCDS0780A) / Roche (0 Trials) |
|
| ilaprazole / Generic mfg. (10 Trials) |
|
| Ilaris (canakinumab) / Novartis (30 Trials) |
|
| ILB-2109 / Innolake Biopharma (0 Trials) |
|
| ILCT-1001 / ILC Therap (0 Trials) |
|
| ilginatinib (NS-018) / Nippon Shinyaku (1 Trials) |
|
| ilofotase alfa oral / AM Pharma (0 Trials) |
|
| iloperidone / Generic mfg. (1 Trials) |
|
| iloprost intravenous (CIVI030) / CiVi Biopharma (0 Trials) |
|
| ilorasertib (ABT348) / AbbVie (0 Trials) |
|
| Ilsira (levilimab) / Biocad (0 Trials) |
|
| iltamiocel (AMDC-USR) / Cook MyoSite (0 Trials) |
|
| Ilumya (tildrakizumab-asmn) / Sun Pharma, Almirall (24 Trials) |
|
| Iluvien (fluocinolone acetonide) / Alimera Sci, EyePoint Pharma (5 Trials) |
|
| ILV-095 / Pfizer (0 Trials) |
|
| IM-4320 / Immunome (0 Trials) |
|
| IM03 / Beijing Imunopharm (0 Trials) |
|
| Im06 / Provecs Medical (0 Trials) |
|
| IM1240 / Purple Biotech (0 Trials) |
|
| IM136 / Integral Molecular (0 Trials) |
|
| IM171 / Integral Molecular (0 Trials) |
|
| IM19 CAR-T cells / Beijing Imunopharm, Simcere (0 Trials) |
|
| IM21 CART / Beijing Imunopharm (0 Trials) |
|
| IM23 / Beijing Imunopharm (0 Trials) |
|
| IM24 / Beijing Imunopharm (0 Trials) |
|
| IM301 / Context Therap (0 Trials) |
|
| IM302 / Context Therap (0 Trials) |
|
| IM73 CAR-T cells / Beijing Imunopharm (0 Trials) |
|
| IM81 / Beijing Imunopharm (0 Trials) |
|
| IM83 / Beijing Imunopharm (0 Trials) |
|
| IM91 / Beijing Imunopharm (0 Trials) |
|
| IM92 / Beijing Imunopharm (0 Trials) |
|
| IM96 CAR-T cells / Beijing Imunopharm (0 Trials) |
|
| IMA 026 / Pfizer (0 Trials) |
|
| IMA-301 / Immatics (0 Trials) |
|
| IMA-901 / Immatics (0 Trials) |
|
| IMA101 / Immatics (1 Trials) |
|
| IMA201 / Immatics (1 Trials) |
|
| IMA202 / Immatics (0 Trials) |
|
| IMA203 / Immatics (0 Trials) |
|
| IMA203CD8 / Immatics (0 Trials) |
|
| IMA204 / Immatics (0 Trials) |
|
|